Form 8-K - Current report:
SEC Accession No. 0001193125-26-071674
Filing Date
2026-02-25
Accepted
2026-02-25 16:20:21
Documents
11
Period of Report
2026-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acad-20260225.htm   iXBRL 8-K 46418
2 EX-99.1 acad-ex99_1.htm EX-99.1 386771
  Complete submission text file 0001193125-26-071674.txt   559598

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20260225.xsd EX-101.SCH 25053
13 EXTRACTED XBRL INSTANCE DOCUMENT acad-20260225_htm.xml XML 4760
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 26678957
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)